1. Ponsegromab at increasing doses resulted in a mean increase in body weight compared to placebo; 1.22 kg (2.21%) in the 100-mg group, 1.92 kg (2.99%) in the 200-mg group, and 2.81 kg (5.46) in the ...
In two cohorts from the UK Biobank and the National Health and Nutrition Examination Survey (NHANES), there was an increased ...
In a randomized double-blind placebo-controlled study, naldemedine use was associated with constipation prevention and a ...
In this cohort study involving noncirrhotic patients with chronic hepatitis B, a new prognostic model based on viral load was ...
Relutrigine resulted in a 46% reduction in seizures and seizure freedom in 30% of patients. Patients also experienced ...
1. In this retrospective observational cohort study of children in St. Louis, those with the highest risk of firearm injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback